Mouse monocyte/macrophage cell line
RAW264 was obtained from RIKEN BRC
(Ibaraki, Japan). The cells were grown in Dulbecco’s modified Eagle
medium (
DMEM: Wako) containing 10% fetal bovine serum with 100 U/ml of
penicillin G and 100 μg/ml of streptomycin at 37°C in 5%
CO
2 with a humidified atmosphere. Subconfluent cells in 12-well
plates were exposed to
LPS (Sigma-Aldrich) at a concentration of 1 μg/ml,
and total RNA was extracted 4 h later. Subsequently, reverse transcription and
PCR were performed as described in the previous section. Predesigned primer sets
for mouse TNF-α (primer set MA097070), IL-6 (primer set MA039013), IL-12A
(primer set MA0287533), IL-23A (primer set MA095159), and TBP (primer set
MA050367) were obtained from the
Perfect Real-Time Supporting System (Takara
Bio). The messenger RNA expression level was normalized to the expression of
TBP. CN210 (0.1, 1 and 10 μM) and dexamethasone (1 μM) were
cotreated with
LPS in
RAW264 cells.
Noguchi T., Hidaka K., Kobayashi S., Matsumoto K., Yoshioka M., Hu X., Maloney D.J., Yang S.M, & Kato S. (2021). A quinazoline-based bromodomain inhibitor, CN210, ameliorates indomethacin-induced ileitis in mice by inhibiting inflammatory cytokine expression. Drug development research, 82(8), 1235-1246.